IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GEOFFREY GOLEMBIEWSKI

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1467460709
CMS profile
65872
Location
ATHENS, GA

General Payments · PY2018–2024

$5,281.65

  • Reported across 295 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$970.43

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nephrology GA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $842.12 41
Education $128.31 12

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $184.19 7
Acerta Pharma LLC $159.69 9
OPKO Pharmaceuticals, LLC $80.40 4
Lilly USA, LLC $78.49 4
Retrophin, Inc. $64.13 9
Amgen Inc. $60.35 3
AKEBIA THERAPEUTICS INC $57.81 3
Boehringer Ingelheim Pharmaceuticals, Inc. $50.77 3
Fresenius USA Marketing, Inc. $44.53 2
Daiichi Sankyo Inc. $42.86 2
Aurinia Pharma U.S., Inc. $42.86 2
Bayer HealthCare Pharmaceuticals Inc. $24.25 1
Ardelyx, Inc. $24.09 1
Otsuka America Pharmaceutical, Inc. $22.13 1
Relypsa, Inc. $17.66 1
CALLIDITAS THERAPEUTICS US INC. $16.22 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $727.73 44
PY2019 $859.86 50
PY2020 $590.45 39
PY2021 $912.93 46
PY2022 $412.25 22
PY2023 $808.00 41
PY2024 $970.43 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $18.54 06/25/2024 Food and Beverage Undisputed 01/23/2026 1145825249 CMS
AKEBIA THERAPEUTICS INC $18.61 09/03/2024 Food and Beverage Undisputed 01/23/2026 1145828584 CMS
AKEBIA THERAPEUTICS INC $20.66 11/18/2024 Food and Beverage Undisputed 01/23/2026 1145831009 CMS
Amgen Inc. $15.78 01/11/2024 Food and Beverage Undisputed 01/23/2026 1111585932 CMS
Amgen Inc. $22.32 06/24/2024 Food and Beverage Undisputed 01/23/2026 1111585934 CMS
Amgen Inc. $22.25 09/18/2024 Food and Beverage Undisputed 01/23/2026 1111585936 CMS
Ardelyx, Inc. $24.09 08/29/2024 Food and Beverage Undisputed 01/23/2026 1146682363 CMS
AstraZeneca Pharmaceuticals LP $19.64 01/08/2024 Food and Beverage Undisputed 01/23/2026 1105624859 CMS
AstraZeneca Pharmaceuticals LP $16.12 02/19/2024 Food and Beverage Undisputed 01/23/2026 1105206123 CMS
AstraZeneca Pharmaceuticals LP $19.56 03/07/2024 Food and Beverage Undisputed 01/23/2026 1105507220 CMS
AstraZeneca Pharmaceuticals LP $17.76 04/15/2024 Food and Beverage Undisputed 01/23/2026 1104553746 CMS
AstraZeneca Pharmaceuticals LP $18.84 05/14/2024 Food and Beverage Undisputed 01/23/2026 1105808468 CMS
AstraZeneca Pharmaceuticals LP $18.04 06/05/2024 Food and Beverage Undisputed 01/23/2026 1105810555 CMS
AstraZeneca Pharmaceuticals LP $19.89 06/11/2024 Food and Beverage Undisputed 01/23/2026 1104733517 CMS
AstraZeneca Pharmaceuticals LP $21.95 08/15/2024 Food and Beverage Undisputed 01/23/2026 1105618473 CMS
AstraZeneca Pharmaceuticals LP $7.89 10/16/2024 Food and Beverage Undisputed 01/23/2026 1104353216 CMS
Aurinia Pharma U.S., Inc. $18.82 02/22/2024 Food and Beverage Undisputed 01/23/2026 1150680981 CMS
Aurinia Pharma U.S., Inc. $24.04 06/27/2024 Food and Beverage Undisputed 01/23/2026 1150680983 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.25 01/29/2024 Food and Beverage Undisputed 01/23/2026 1086242540 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.44 06/05/2024 Food and Beverage Undisputed 01/23/2026 1118020830 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.43 07/18/2024 Food and Beverage Undisputed 01/23/2026 1118020834 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.90 09/17/2024 Food and Beverage Undisputed 01/23/2026 1118020832 CMS
CALLIDITAS THERAPEUTICS US INC. $16.22 09/19/2024 Food and Beverage Undisputed 01/23/2026 1141522543 CMS
Daiichi Sankyo Inc. $16.29 02/08/2024 Food and Beverage Undisputed 01/23/2026 1089426841 CMS
Daiichi Sankyo Inc. $26.57 09/26/2024 Food and Beverage Undisputed 01/23/2026 1089426843 CMS
Fresenius USA Marketing, Inc. $24.08 02/27/2024 Food and Beverage Undisputed 01/23/2026 1154204242 CMS
Fresenius USA Marketing, Inc. $20.45 04/22/2024 Food and Beverage Undisputed 01/23/2026 1154204240 CMS
Lilly USA, LLC $16.67 02/14/2024 Food and Beverage Undisputed 01/23/2026 1134985840 CMS
Lilly USA, LLC $16.72 06/27/2024 Food and Beverage Undisputed 01/23/2026 1134997978 CMS
Lilly USA, LLC $22.84 09/18/2024 Food and Beverage Undisputed 01/23/2026 1135003539 CMS
Lilly USA, LLC $22.26 10/10/2024 Food and Beverage Undisputed 01/23/2026 1134985838 CMS
Novartis Pharmaceuticals Corporation $23.38 02/29/2024 Food and Beverage Undisputed 01/23/2026 1086941515 CMS
Novartis Pharmaceuticals Corporation $23.38 04/30/2024 Food and Beverage Undisputed 01/23/2026 1086941521 CMS
Novartis Pharmaceuticals Corporation $22.11 05/15/2024 Food and Beverage Undisputed 01/23/2026 1086941523 CMS
Novartis Pharmaceuticals Corporation $26.04 08/28/2024 Food and Beverage Undisputed 01/23/2026 1086941529 CMS
Novartis Pharmaceuticals Corporation $24.48 10/10/2024 Food and Beverage Undisputed 01/23/2026 1086941527 CMS
Novartis Pharmaceuticals Corporation $38.15 11/19/2024 Food and Beverage Undisputed 01/23/2026 1086941531 CMS
Novartis Pharmaceuticals Corporation $26.65 12/11/2024 Food and Beverage Undisputed 01/23/2026 1086941533 CMS
OPKO Pharmaceuticals, LLC $20.49 03/25/2024 Education Undisputed 01/23/2026 1112844844 CMS
OPKO Pharmaceuticals, LLC $19.33 04/10/2024 Education Undisputed 01/23/2026 1112844846 CMS
OPKO Pharmaceuticals, LLC $21.19 08/27/2024 Education Undisputed 01/23/2026 1112844848 CMS
OPKO Pharmaceuticals, LLC $19.39 12/10/2024 Education Undisputed 01/23/2026 1112844850 CMS
Otsuka America Pharmaceutical, Inc. $22.13 10/09/2024 Food and Beverage Undisputed 01/23/2026 1118899016 CMS
Travere Therapeutics, Inc. $3.08 02/21/2024 Education Undisputed 01/23/2026 1149895306 CMS
Travere Therapeutics, Inc. $16.22 02/21/2024 Food and Beverage Undisputed 01/23/2026 1149895322 CMS
Travere Therapeutics, Inc. $16.89 02/21/2024 Education Undisputed 01/23/2026 1149895326 CMS
Travere Therapeutics, Inc. $0.37 05/22/2024 Education Undisputed 01/23/2026 1149895298 CMS
Travere Therapeutics, Inc. $3.08 05/22/2024 Education Undisputed 01/23/2026 1149895310 CMS
Travere Therapeutics, Inc. $16.89 05/22/2024 Education Undisputed 01/23/2026 1149895329 CMS
Travere Therapeutics, Inc. $0.37 08/21/2024 Education Undisputed 01/23/2026 1149895302 CMS
Travere Therapeutics, Inc. $3.08 08/21/2024 Education Undisputed 01/23/2026 1149895314 CMS
Travere Therapeutics, Inc. $4.15 08/21/2024 Education Undisputed 01/23/2026 1149895318 CMS
Vifor Pharma, Inc. $17.66 02/01/2024 Food and Beverage Undisputed 01/23/2026 1124035381 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.